Diversicare Announces 2020 Third Quarter Results

Diversicare Healthcare Services, Inc. DVCR, a premier provider of long-term care services, today announced its results for the third quarter ended September 30, 2020.

Third Quarter 2020 Highlights

• Net income from continuing operations was $3.2 million, or $0.48 per share, in the third quarter of 2020, compared to net loss from continuing operations of $(1.9) million, or $(0.30) per share, in the third quarter of 2019.
• EBITDA for the quarter was $6.7 million, which was $5.5 million higher than the third quarter of 2019 and $1.2 million higher than the preceding quarter.
• EBITDAR for the quarter was $20.2 million.

See below for a reconciliation of all GAAP and non-GAAP financial results.

CEO Remarks

Commenting on the quarter, Jay McKnight, President and Chief Executive Officer, said, "Despite the impact of the COVID-19 pandemic continuing to challenge our company, this quarter the Diversicare team performed exceptionally well operationally and continued to realize financial gains from cost saving initiatives made during the prior year. The regional and local teams have heroically cared for our patients and residents while dealing with COVID-19 cases in all of our 62 centers at some point during the pandemic. We are so proud of the accomplishments and improvements made by our team in this constantly changing regulatory environment."

Mr. McKnight continued, "Earlier this week we announced a new partnership with Reliant Rehabilitation to be our therapy provider in all of our centers. We believe that this transition will equip us to continue to be a care innovator and ensure that we can provide the best quality of care to our patients and residents. We also expect cost savings from efficiencies gained by this new relationship. This is one of many ways we are striving to continue improving our company so that we will come out of the pandemic better prepared to be an industry leader and high quality provider."

COVID-19 Update

We have received federal support by way of stimulus grants totaling $42.3 million that must be used to offset lost revenue or excess expenses incurred to fight COVID-19. Several of our states have temporarily increased our Medicaid rates to assist with the costs of dealing with the pandemic. We anticipate that we will incur significant expense and lost revenue in the fourth quarter and beyond related to fighting this disease.

The CDC and Centers for Medicare and Medicaid Services ("CMS") has continued to expand reporting guidelines for our centers to follow. Reporting guidance requires notifying residents and designated representatives of the occurrence of a single confirmed COVID-19 positive case, any subsequent positive cases, any COVID-19 positive new admission, and/or three or more cases of new onset respiratory symptoms occurring within 72 hours. Our centers remain compliant with regular reporting to the CDC and CMS regarding the number of COVID-19 cases in our centers, patient deaths, and other information. This information is reported in accordance with existing privacy regulations and statues for the safety and well-being of our residents.

The CDC has recently announced the addition of Point of Care ("POC") Test Reporting that will charge our centers with the responsibility of reporting comprehensive test result data on a reoccurring basis. The frequency of reporting will vary by center as it is determined by the center's COVID-19 status and community positivity rate.

We are committed to keeping our residents and their designated representatives informed as we continue to navigate COVID-19 in our centers. We will continue to report aggregated COVID-19 data for the company our website at https://dvcr.com/our-response-to-covid-19/ and provide center specific information on each of our center's websites.

Third Quarter 2020 Results

The following table summarizes key revenue and census statistics for continuing operations for each period:

Patient revenues were $118.0 million and $118.6 million for the three months ended September 30, 2020 and 2019, respectively, a decrease of $0.6 million.

Our Medicaid, Medicare and Managed Care rates for the third quarter of 2020 increased 2.8%, 10.8% and 10.6%, respectively, resulting in a revenue increase of $1.5 million, $1.9 million and $0.9 million, respectively. Our Medicaid, Private, Managed Care and Hospice average daily census for the third quarter of 2020 decreased 18.4%, 16.7%, 4.8% and 5.5%, respectively, resulting in lost revenue of $12.0 million, $1.4 million, $0.4 million and $0.5 million, respectively. Our Medicare census for the third quarter of 2020 increased 13.2% resulting in increased revenue of $2.8 million. The decline in census for the third quarter of 2020 was mainly due to the impact of the COVID-19 pandemic. We recognized $6.6 million Medicaid state stimulus funds during the third quarter of 2020. Additionally, the suspension of sequestration for the third quarter of 2020 resulted in an increase in revenue of $0.7 million.

During the nine month period ended September 30, 2020, we received $42.3 million of provider relief from the Public Health and Social Services Emergency Fund. We recognized $9.6 million of the funds during the third quarter of 2020, which is classified as "Other Operating Income" in the Company's results of operations for the three month period ended September 30, 2020. The Medicare stimulus funds that we recognized during the quarter were used to offset healthcare-related expenses and lost revenues attributable to COVID-19. Increased healthcare related expenses included but were not limited to increased wages and increased costs for personal protective equipment, testing and other supplies.

Operating expense increased in the third quarter of 2020 to $98.7 million from $95.6 million in the third quarter of 2019, an increase of $3.1 million. Operating expense increased as a percentage of patient revenues to 83.7% for the third quarter of 2020 as compared to 80.6% for the third quarter of 2019.

The primary driver for the increase in operating expense was COVID-19 related expenses of $12.7 million. COVID-19 expenses included increased wages and increased cost for personal protective equipment, testing, food and certain other supplies. Excluding COVID-19, we benefited from our cost saving initiatives including decreased wages of $5.4 million to $52.8 million in the third quarter of 2020, compared to $58.2 million in the third quarter of 2019. Additionally, our nursing and ancillary and health insurance costs decreased by $1.8 million and $1.4 million, respectively.

Lease expense in the third quarter of 2020 increased to $13.5 million as compared to $13.3 million in the third quarter of 2019, an increase of $0.2 million. The increase in lease expense was due to rent increases resulting from the amendment to the Lease with Omega Healthcare Investors in conjunction with the Kentucky Exit.

Professional liability expense was $2.2 million and $1.7 million in the third quarters of 2020 and 2019, respectively. Our cash expenditures for professional liability costs, including those relative to claims for the centers that we formerly operated in the State of Kentucky, were $1.8 million and $1.9 million for the third quarters of 2020 and 2019, respectively. Professional liability expense fluctuates based on the results of our third-party professional liability actuarial studies, premiums and cash expenditures are incurred to defend and settle existing claims.

General and administrative expense was $6.5 million for the third quarter of 2020 compared to $6.9 million for the third quarter of 2019, a decrease of $0.4 million or 6.0%.

Depreciation and amortization expense decreased to $2.1 million for the third quarter of 2020 compared to $2.3 million in the third quarter of 2019.

Interest expense was $1.2 million in the third quarter of 2020 and $1.6 million in the third quarter of 2019. The decrease of $0.4 million was due to a decrease in the outstanding borrowings on our loan facilities.

The Company recorded income tax provision for continuing operations of $0.2 million and income tax benefit of $0.7 million during the third quarters of 2020 and 2019, respectively.

As a result of the above, continuing operations reported income of $3.4 million before income taxes for the third quarter of 2020 as compared to a loss of $2.7 million for the third quarter of 2019. Both basic and diluted income per common share from continuing operations were $0.48 for the third quarter of 2020 as compared to both basic and diluted loss per common share from continuing operations of $0.30 in the third quarter of 2019.

COVID-19 Impact on Continuing Operations

Since the end of the quarter, there have been additional cases of COVID-19 at certain of our centers. The Company has continued to experience reduced occupancy and increased operating expenses at its centers in the form of increased wages and increased cost for personal protective equipment, food and certain other supplies. The Company expects such increased expenses to continue and likely increase further during the remainder of 2020.

Receivables

Our net receivables balance decreased $9.9 million to $50.6 million as of September 30, 2020, from $60.5 million as of December 31, 2019.

Conference Call Information

A conference call has been scheduled for Thursday, November 5, 2020 at 4:00 P.M. Central time (5:00 P.M. Eastern time) to discuss third quarter 2020 results. The conference call information is as follows:

A replay of the conference call will be accessible two hours after its completion through November 12, 2020, by dialing 800-633-8284 and entering Access Code: 21971704.

FORWARD-LOOKING STATEMENTS

The "forward-looking statements" contained in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. These forward-looking statements reflect our current views with respect to future events and present our estimates and assumptions only as of the date of this release. Actual results could differ materially from those contemplated by the forward-looking statements made in this release. In addition to any assumptions and other factors referred to specifically in connection with such statements, other factors, many of which are beyond our ability to control or predict, could cause our actual results to differ materially from the results expressed or implied in any forward-looking statements including, but not limited to, the potential adverse effect of the COVID-19 pandemic on the economy, our patients and residents and supply chain, including, changes in the occupancy of our centers, increased operation costs in addressing COVID-19, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operations challenges faced by its patients served, the duration and severity of the COVID-19 pandemic and the extent and severity of the impact on the Company's patients and residents, actions governments take in response to the COVID-19 pandemic, including the introduction of public health measures and other regulations affecting our centers, the impact of the CARES Act, the Paycheck Protection Program and Health Care Enhancement Act and any other COVID-19 relief aid adopted by governments or the implementation or modifications to such acts, including any obligation of the Company to repay any stimulus payments received under such relief aid, perceptions regarding the safety of senior living communities during and after the pandemic, changes in demand for senior living communities and our ability to adapt our sales and marketing efforts to meet the demand, changes in the acuity levels of our new residents, the disproportionate impact of COVID-19 on seniors generally and those residing in our communities, increased regulatory requirements, including unfunded mandatory testing, increased enforcement actions resulting from COVID-19, including those that may limit our collection efforts for delinquent accounts and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or our response efforts, our ability to successfully integrate the operations of new nursing centers, as well as successfully operate all of our centers, our ability to increase census at our centers and occupancy rates at our centers, changes in governmental reimbursement, including the new Patient-Driven Payment Model that was implemented in October of 2019, government regulation, the impact of the Affordable Care Act, efforts to repeal or further modify the Affordable Care Act, and other health care reform initiatives, any increases in the cost of borrowing under our credit agreements, our ability to comply with covenants contained in those credit agreements, our ability to comply with the terms of our master lease agreements, our ability to renew or extend our leases at or prior to the end of the existing lease terms, the outcome of professional liability lawsuits and claims, our ability to control ultimate professional liability costs, the accuracy of our estimate of our anticipated professional liability expense, the impact of future licensing surveys, the outcome of proceedings alleging violations of state or Federal False Claims Acts, laws and regulations governing quality of care or other laws and regulations applicable to our business including HIPAA and laws governing reimbursement from government payors, the costs of investing in our business initiatives and development, our ability to control costs, our ability to attract and retain qualified healthcare professionals, changes to our valuation of deferred tax assets, changing economic and competitive conditions, changes in anticipated revenue and cost growth, changes in the anticipated results of operations, the effect of changes in accounting policies as well as others.

The Company has provided additional information in its Annual Report on Form 10-K for the fiscal year ended December 31, 2019, as well as in its other filings with the Securities and Exchange Commission, which readers are encouraged to review for further disclosure of other factors. These assumptions may not materialize to the extent assumed, and risks and uncertainties may cause actual results to be different from anticipated results. These risks and uncertainties also may result in changes to the Company's business plans and prospects. Diversicare Healthcare Services, Inc. is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

Diversicare provides long-term care services to patients in 62 nursing centers and 7,329 skilled nursing beds. For additional information about the Company, visit Diversicare's web site: www.DVCR.com.

-Financial Tables to Follow-

We have included certain financial performance and valuation measures in this press release, including EBITDA and EBITDAR which are "non-GAAP financial measures" using accounting principles generally accepted in the United States (GAAP) and using adjustments to GAAP (non-GAAP). These non-GAAP measures are not measurements under GAAP. These measurements should be considered in addition to, but not as a substitute for, the information contained in our financial statements prepared in accordance with GAAP. We define EBITDA as net income (loss) adjusted for loss from discontinued operations, interest expense, income tax and depreciation and amortization. We define EBITDAR as EBITDA adjusted for rent expense.

Our measurements of EBITDA and EBITDAR may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA in this press release because we believe that such information is used by certain investors as measures of the Company's historical performance. Our presentation of EBITDA should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items.

We have included EBITDAR in this press release because we believe that such information is used by certain investors as measures of the Company's valuation. We believe that EBITDAR is an important financial valuation measure that is commonly used by our management, research analysts, investors, lenders and financial institutions, to compare the enterprise value of different companies in the healthcare industry, without regard to differences in capital structures and leasing arrangements. EBITDAR is a financial valuation measure and is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense. As such, our presentation of EBITDAR, should not be construed as a financial performance measure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201105006149/en/